Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials

#JITC Commentary: Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials https://t.co/um3DImPcd9 https://t.co/qKeuMD

#JITC Commentary: Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials https://t.co/um3DImPcd9 https://t.co/BKhxqu

RT @sitcancer: #JITC Commentary: Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therap…

RT @sitcancer: #JITC Commentary: Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therap…